Stockscreener 앱 받기
0.6297
3.12%
-0.0203
전일 마감가:
$0.65
열려 있는:
$0.62
하루 거래량:
239.15K
Relative Volume:
0.74
시가총액:
$N/A
수익:
$237.26M
순이익/손실:
$16.33M
주가수익비율:
10.62
EPS:
0.0593
순현금흐름:
$7.57M
1주 성능:
-9.27%
1개월 성능:
-13.74%
6개월 성능:
+61.46%
1년 성능:
-35.85%
1일 변동 폭
$0.60
$0.6452
1주일 범위
$0.60
$0.7038
52주 변동 폭
$0.33
$0.80
Vaxart Inc Stock (VXRT) Company Profile
Compare VXRT vs VRTX, REGN, ARGX, ALNY, INSM
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VXRT
Vaxart Inc
|
0.6297 | 0 | 237.26M | 16.33M | 7.57M | 0.0593 |
VRTX
Vertex Pharmaceuticals Inc
|
447.26 | 113.44B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
777.25 | 81.68B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
743.12 | 45.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.73 | 43.88B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
164.86 | 35.25B | 606.42M | -1.28B | -997.58M | -6.403 |
Vaxart Inc Stock (VXRT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-08-15 | 개시 | Oppenheimer | Outperform |
| 2021-12-29 | 재개 | Jefferies | Buy |
| 2021-11-02 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-06-29 | 다운그레이드 | B. Riley Securities | Buy → Neutral |
| 2021-06-24 | 개시 | Jefferies | Buy |
| 2021-06-11 | 개시 | Piper Sandler | Overweight |
| 2020-08-12 | 재확인 | H.C. Wainwright | Buy |
| 2020-07-13 | 개시 | B. Riley FBR | Buy |
모두보기
Vaxart Inc 주식(VXRT)의 최신 뉴스
Tax withholding trims Vaxart (NASDAQ: VXRT) SVP Sean Tucker RSU shares - stocktitan.net
Vaxart (NASDAQ: VXRT) CMO shares withheld to cover RSU tax obligations - stocktitan.net
VXRT (Vaxart) Purchase Of Investment : $-23.2 Mil (TTM As of Dec. 2025) - GuruFocus
Vaxart (NASDAQ: VXRT) SVP Berg has 36,418 shares withheld for RSU tax obligations - stocktitan.net
Vaxart (VXRT) CMO settles RSU taxes with 30,551 withheld shares - stocktitan.net
Vaxart (NASDAQ: VXRT) CEO has shares withheld to cover RSU taxes - stocktitan.net
Vaxart (NASDAQ: VXRT) SVP Sean Tucker reports RSU tax-withholding event - stocktitan.net
Swing Trade: What drives Par Pacific Holdings Incs stock priceStock Surge & Risk Controlled Daily Plans - baoquankhu1.vn
Vaxart (VXRT) SVP Berg has 8,072 shares withheld to cover RSU taxes - Stock Titan
Vaxart (VXRT) CMO reports 6,772-share tax withholding, holds 958,020 shares - Stock Titan
Vaxart (VXRT) CEO Steven Lo reports RSU tax withholding of 22,425 shares - stocktitan.net
Vaxart (VXRT) SVP Sean Tucker reports RSU tax-withholding disposition - Stock Titan
Vaxart, Inc. (NASDAQ:VXRT) Q4 2025 Earnings Call Transcript - Insider Monkey
Vaxart (VXRT) CEO Steven Lo receives major stock option and RSU grants - stocktitan.net
Vaxart (VXRT) CSO Sean Tucker awarded 410K options and 200K shares - Stock Titan
Vaxart (VXRT) CFO granted 227,000 shares and 455,000 options in Form 4 - Stock Titan
Vaxart (NASDAQ: VXRT) CMO receives new stock options and RSUs - Stock Titan
Vaxart (NASDAQ: VXRT) SVP and General Counsel granted shares and options - Stock Titan
Trading Recap: Is Vaxart Inc a play on infrastructure spendingCPI Data & Daily Risk Controlled Trade Plans - baoquankhu1.vn
Risk Off: Is Vaxart Inc still a buy after recent gainsWeekly Trade Recap & Community Trade Idea Sharing - baoquankhu1.vn
Vaxart (VXRT) Short Interest & Short Float | Updated Mar 2026 $VXRT - MarketBeat
High-Potential Stocks Under $5 to Watch in 2026 - TradingKey
Vaxart (VXRT) Revenue Surge To US$72.4 Million Tests Bearish Decline Narrative - simplywall.st
VXRT: Oral vaccine platform advances with global partnerships, cost savings, and key data expected in 2026 - TradingView
Vaxart (OTCMKTS:VXRT) Releases Quarterly Earnings Results, Beats Expectations By $0.32 EPS - MarketBeat
Vaxart, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Vaxart (OTCQX: VXRT) outlines progress on oral norovirus and COVID vaccines - Stock Titan
Vaxart signals $700M COVID-19 vaccine milestone path as Sanofi partnership advances and 2026 data readouts approach - MSN
Vaxart Q4 Earnings Call Highlights - MarketBeat
Vaxart Inc (VXRT) Q4 2025 Earnings Call Highlights: Revenue Surge and Strategic Partnerships Propel Growth - GuruFocus
Vaxart (VXRT) Reports Strong Revenue Growth in 2025 - GuruFocus
Vaxart Q4 2025 Earnings Call Transcript - MarketBeat
Earnings call transcript: Vaxart’s Q4 2025 revenue surges, stock reacts - Investing.com
VAXART ($VXRT) Releases Q4 2025 Earnings - Quiver Quantitative
Vaxart (OTCQX: VXRT) turns 2025 profit as revenue jumps to $237M - Stock Titan
Vaxart, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Vaxart (VXRT) Set to Release Q4 Earnings Report - GuruFocus
Vaxart Q4 2025 earnings preview - msn.com
Vaxart (VXRT) to Release Earnings on Thursday - MarketBeat
Why Vaxart Inc. stock attracts high net worth investorsQuarterly Trade Summary & Weekly High Return Forecasts - Naître et grandir
RFK Jr. pauses $240 million contract for new ‘oral COVID vaccine’ - todayville.com
Vaxart to Host Upcoming Conference Calls - The Manila Times
VXRT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Is Vaxart's (VXRT) Conference Spotlight Reframing the Oral Vaccine Story or Just Polishing It? - Yahoo Finance
Vaxart, Inc. (VXRT) Presents at Oppenheimer 36th Annual Healthcare Life Sciences ConferenceSlideshow - Seeking Alpha
3 Stocks Under $5 With Strong Analyst Upside Potential - Investing.com
3 Stocks Under $5 With Strong Analyst Upside Potential - Investing.com
Vaxart (OTCMKTS:VXRT) Stock Price Passes Above Fifty Day Moving AverageWhat's Next? - MarketBeat
Vaxart (VXRT) Earnings Date and Reports 2026 $VXRT - marketbeat.com
Vaxart (VXRT) Stock Price, News & Analysis $VXRT - marketbeat.com
Vaxart (VXRT) Institutional Ownership 2026 $VXRT - marketbeat.com
Vaxart Inc (VXRT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.52%
0.51%
자본화:
|
볼륨(24시간):